Thrombectomy Device Articles & Analysis
5 news found
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical removal of thrombi or emboli from the pulmonary arteries and for ...
It is the only device that adjusts to the vasculature and clot, a more atraumatic approach than existing devices. “The neurovascular field has been waiting for a thrombectomy device dedicated to small vessels,” states Dr. David Fiorella of Stony Brook University Medical Center in Stony Brook, NY. ...
Rapid Medical, a leading developer of advanced neurovascular devices, announced today the enrollment of the first patient in the DISTALS Study. The trial is the first-ever FDA investigational device exemption (IDE) trial to examine the safety and effectiveness of mechanical thrombectomy in distal stroke. ...
BrainQ’s investigational neurorecovery technology has been granted FDA Breakthrough Device Designation, and is set to be trialed in a multicenter pivotal study for stroke patients in select hospitals across the US. ...
PLANO, Texas, Jan. 5, 2016 /PRNewswire/ -- Argon Medical Devices, Inc. announced the completed acquisition of three vascular products from Rex Medical, LLC. The OptionELITE™ Retrievable Vena Cava Filter, CLEANER™ Rotational Thrombectomy System, and UltraStream™ Chronic Hemodialysis Catheter are now wholly owned by Argon Medical ...